Bristol-Myers Squibb Co at JPMorgan Healthcare Conference Transcript
Good morning, everybody. I'm Chris Schott from JPMorgan, and welcome to the 44th Annual JPMorgan Healthcare Conference. It's great to see everybody today. So it's my pleasure to be again -- to be introducing Bristol-Myers to again kick off the conference this year. From the company, we have Chairman and CEO, Chris Boerner. Chris is going to do a quick presentation, and then we're going to go to a fireside format from there.
So with that, we'll turn it over to Chris. So happy New Year presentation. Thanks, Chris.
Thank you, Chris, for the introduction, and it is fantastic to be back kicking off another JPMorgan Healthcare Conference. Obviously, we're going to be making some forward-looking statements today, so these are my disclosures. Let me start with just a reminder of our overarching goal as a company. We remain focused on building a company that's strong financially and has the substrate to deliver
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
